Patent · US Active

Macrocyclic compounds for modulating IL-17

US9284283B2 · kind B2 · utility

3Cited by

20References

16Claims

0Family size

Assignee

Ensemble Therapeutics Corporation · US

Inventors

Michael D. Taylor · Ann Arbor, US
Nicholas K. Terrett · Brookline, US
William H. Connors · Lynnfield, US
Cheri Snedeker · Nashua, US
Kelley C. Shortsleeves · Maynard, US
Benjamin A. Seigal · Watertown, US
Stephen Hale · Belmont, US
Timothy F. BRIGGS · Waltham, US
Frank G. Favaloro · Attleboro, US
Tyler J. Cipriani · Preston, US
Dingxue Yan · Grafton, US
Sethu L. Alexander · Westford, US
Atli Thorarensen · O'Fallon, US
Li Xing · Lexington, US

Key dates

Filing date	Feb 1, 2013
Grant date	Mar 15, 2016
Priority date	—
Expiry date	Feb 1, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates generally to macrocyclic compounds of formula I and their therapeutic use. More particularly, the invention relates to macrocyclic compounds that modulate the activity of IL-17 and/or are useful in the treatment of medical conditions, such as inflammatory diseases and other IL-17-associated disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.